Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD

NCT06475781 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Group 3 Pulmonary Hypertension

Interventions

DRUG: Mirivadelgat
DRUG: placebo

Sponsor

Foresee Pharmaceuticals Co., Ltd.

Collaborators

[object Object]